Products found to contain undeclared medicines
|
| |
| The United States: EnShiShiXiangNiShangMaoYouXianGongSi issues voluntary nationwide recall of ENDURANCE BOOST WITH HORNY GOAT WEED Capsules due to presence of undeclared propoxyphenylsildenafil and sildenafil |
| |
The United States Food and Drug Administration (FDA) announces that EnShiShiXiangNiShangMaoYouXianGongSi is voluntarily recalling one lot of ENDURANCE BOOST WITH HORNY GOAT WEED (20 Count) capsules (lot number: 250214PRO) to the consumer level. During the regular sampling, the product has been found to be tainted with Propoxyphenylsildenafil (a sildenafil analogue) and Sildenafil.
Sildenafil is an ingredient in FDA approved products for treatment of male erectile dysfunction in the family of drugs known as phosphodiesterase (PDE-5) inhibitors. Products containing sildenafil cannot be marketed as dietary supplements. ENDURANCE BOOST WITH HORNY GOAT WEED is an unapproved new drug for which safety and efficacy have not been established and, therefore, subject to recall.
Consumption of products with undeclared sildenafil and its analogue propoxyphenylsildenafil, may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population, who are most likely to use this product, adult males who use nitrates for cardiac conditions are most at risk.
To date April 30, 2025, EnShiShiXiangNiShangMaoYouXianGongSi has not received any reports of adverse events related to this recall. This tainted product is marketed as a nutrition supplement for male performance and energy.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/enshishixiangnishangmaoyouxiangongsi-issues-voluntary-nationwide-recall-endurance-boost-horny-goat
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, May 7, 2025
Issued at HKT 15:00
|
| |
